(Q38698476)

5 September 2017

Vaccination of horses with Lyme vaccines for dogs induces short-lasting antibody responses (English)

1 reference

5 September 2017

0 references

Cassandra Guarino

1

1 reference

5 September 2017

Sanda Asbie

2

1 reference

5 September 2017

Jennifer Rohde

3

1 reference

5 September 2017

Amy Glaser

4

1 reference

5 September 2017

Bettina Wagner

5

1 reference

5 September 2017

language of work or name

English

0 references

publication date

28 June 2017

1 reference

5 September 2017

1 reference

5 September 2017

35

1 reference

5 September 2017

33

1 reference

5 September 2017

4140-4147

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

5 September 2017

1 reference

ACVIM small animal consensus statement on Lyme disease in dogs: diagnosis, treatment, and prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

A case of Borrelia-associated cutaneous pseudolymphoma in a horse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Diagnosis of Borrelia-associated uveitis in two horses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Meningitis, cranial neuritis, and radiculoneuritis associated with Borrelia burgdorferi infection in a horse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Lyme neuroborreliosis in 2 horses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Retrospective Evaluation of Horses Diagnosed with Neuroborreliosis on Postmortem Examination: 16 Cases (2004-2015).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Antibodies to OspC, OspF and C6 antigens as indicators for infection withBorrelia burgdorferiin horses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Vaccination against lyme disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

OspA lipoprotein of Borrelia burgdorferi is a mucosal immunogen and adjuvant.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Safety, efficacy, and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Transcriptional regulation of the ospAB and ospC promoters from Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

The prevention of Lyme disease with vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Characterization and optimization of a novel vaccine for protection against Lyme borreliosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Protection of mice against the Lyme disease agent by immunizing with recombinant OspA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Lyme disease: laboratory diagnosis of infected and vaccinated symptomatic dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Characterization of the humoral immune response in dogs after vaccination against the Lyme borreliosis agent A study with five commercial vaccines using two different vaccination schedules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Essential role for OspA/B in the life cycle of the Lyme disease spirochete

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Adaptation of Borrelia burgdorferi in the vector and vertebrate host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Inhibition of Borrelia burgdorferi migration from the midgut to the salivary glands following feeding by ticks on OspC-immunized mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Development of an OspC-based tetravalent, recombinant, chimeric vaccinogen that elicits bactericidal antibody against diverse Lyme disease spirochete strains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Antibody and cellular immune responses of naïve mares to repeated vaccination with an inactivated equine herpesvirus vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Neonatal Immunization with a Single IL-4/Antigen Dose Induces Increased Antibody Responses after Challenge Infection with Equine Herpesvirus Type 1 (EHV-1) at Weanling Age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Antibodies to Borrelia burgdorferi OspA, OspC, OspF, and C6 antigens as markers for early and late infection in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

West Nile virus-specific immunoglobulin isotype responses in vaccinated and infected horses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Western blotting in the serodiagnosis of Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Comparable immune responsiveness but increased reactogenicity after subcutaneous versus intramuscular administration of tick borne encephalitis (TBE) vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

inferred from DOI database lookup

7 January 2021

based on heuristic

Serodiagnosis of Lyme borreliosis by western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.06.052

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2017.06.052

1 reference

5 September 2017

1 reference